KLRC1 and chronic myelogenous leukemia, BCR-ABL1 positive: Our results showed a significant decrease in the expression of the inhibitory receptor NKG2A on CD56dim NK cells in middle-aged CML patients compared with middle-aged healthy donors and a decrease in the percentage of NKG2A+CD56bright NK cells in old CML patients compared with old healthy donors.